SPRO
Spero Therapeutics, Inc. · Healthcare
Aquilo Capital Management, LLC bought $2.5M of Spero Therapeutics, Inc.
10% owner
Bought$2,509,173
$18.65Price
134,543Shares
+3%Stake
What SPRO did for a copier
- $1,000 copied at Mon, Oct 4 close, $18.08
- $908
- S&P 500, same days
- +9.0%
Measured over 30 trading days, to the Nov 15 close.
Aquilo Capital Management, LLC's record
12 other buys with 3 months of prices since 2021: on average −61.0% against the S&P 500, and 0 of 12 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Sep 30. Filed Mon, Oct 4, 11:36 AM ET, during the session. Returns use the Oct 4 close and the Nov 15 close. Not investment advice.